Abingworth Management Inc Company Profile

06:22 EDT 24th March 2018 | BioPortfolio

Abingworth is a long-established venture capital firm dedicated to the life sciences sector on both sides of the Atlantic. The company invests across all stages of development, including early-stage as well as public companies. Abingworth has provided backing for more than 90 unquoted life science businesses.

The majority of these have gone public or have merged or been acquired. Abingworth has funds under management of more than $750 million. Founded in 1973, Abingworth has offices in London, Cambridge (UK), Menlo Park (California) and Boston.

Abingworth’s funds are exclusively dedicated to life sciences. Abingworth’s team has a strong scientific background in addition to business, financial and other specialist skills. These include legal, investment banking, fund-raising as well as operating and recruiting capabilities. These resources are extended to portfolio companies in order to help build successful companies. Abingworth’s team offering is further complemented by a network of scientific and industry consultants who contribute to the process of evaluating new opportunities, creating companies and supporting existing portfolio investments.
This combination of broad-ranging experience and resources enables Abingworth to assist companies at any stage of development, including during and after the IPO process.

Abingworth seeks to invest in the best opportunities in the life sciences market. Investments have been made in platform and enabling technologies, devices and instrumentation as well as in companies developing products in a range of therapeutic areas.

Abingworth’s investments are based in the US and Europe including the UK, Belgium, Denmark, France, Germany, Holland and Sweden. Abingworth’s investments range from $1 to $25 million, averaging around $15 million per investment after all private rounds of financing.


3000 Sand Hill Road Bldg. 4, Suite 135
Menlo Park
United States of America


Phone: 650 926 0600
Fax: 650 926 9782

News Articles [498 Associated News Articles listed on BioPortfolio]

VirionHealth secures Abingworth backing to trial novel antiviral studies

VirionHealth Ltd is poised to start Phase I trials of new biological antivirals - called defective interfering particles - after receiving Â13m ($15m) from private equity group Abingworth.

Two-Year Old Biotech NousCom Nabs $49M to Fund New Drug Into Clinic

The round was led by new investor Abingworth with participation from another new investor, 5AM Ventures, LSP and Versant Ventures.

Series A brings in £13mm for VirionHealth

Recently formed VirionHealth Ltd. raised £13mm ($17mm) in its Series A financing to Abingworth, which adds a board member.

NousCom Raises EUR42 Million Series B Financing

NousCom, an oncology company developing neoantigen based cancer vaccines based on its Exovax platform, today announced the completion of a EUR42 million Series B financing. The round involved a syndic...

Swiss Biotech Pulls Major Investors into €42M Series B for Cancer Vaccines

NousCom is developing semi-personalized medicine that convinced investors like Abingworth to go in big for its off-the-shelf neoantigen vaccines. Based in Basel and run by a team of serial entrepreneu...

Airway Management in Trauma

The process of airway management has evolved considerably to include rapid sequence intubation (RSI), the use of various procedures, and sophisticated devices designed to assist in the placement of an...

Free Research Reports on These Asset Management Stocks -- Och-Ziff Capital Management, State ...

Och-Ziff Capital Management Group New York City-based Och-Ziff Capital Management Group LLC's stock finished Wednesday's session 1.50% lower at $2.63. A total volume Read more...

Cancer vaccines company Nouscom raises €42mm in Series B round

Nouscom AG (cancer vaccines) raised €42mm ($48.7mm) in its Series B financing round from new backers Abingworth (led) and 5AM Ventures. Returning investors LSP (Life Sciences Partners) and Versant V...

PubMed Articles [1791 Associated PubMed Articles listed on BioPortfolio]

Testicular Torsion: Current Evaluation and Management.

Testicular torsion is a urologic emergency, requiring prompt identification and management. Understanding the risk factors, presentation, and management is essential to decrease delays in diagnosis an...

Patients' perspectives of care management: a qualitative study.

Risk-stratified care management is a cornerstone of patient-centered medical home models, but studies on patients' perspectives of care management are scarce. We explored patients' experiences with ca...

"Risk management" is a verb.

To optimally demonstrate the value of risk management, our actions must show the benefits. The American Society for Healthcare Risk Management (ASHRM) board needs to provide support through tools and ...

Self-management strategies in chronic obstructive pulmonary disease: a first step toward personalized medicine.

Self-management has gained increased relevance in the management of chronic obstructive pulmonary disease patients. The heterogeneity in self-management interventions has complicated the development o...

Can Multimodal Pain Management in TKA Eliminate Patient-controlled Analgesia and Femoral Nerve Blocks?

TKA pain management protocols vary widely with no current consensus on a standardized pain management regimen. Multimodal TKA pain management protocols aim to address pain control, facilitate function...

Clinical Trials [2320 Associated Clinical Trials listed on BioPortfolio]

Hepatitis C Self-Management

The objective of this study is to compare the efficacy of a 6-session hepatitis C self-management workshop to a hepatitis C self-management self-study program. Both interventions are desig...

Contingency Management Treatment Duration

310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatmen...

Self-care Management Program for Dry Eye Disease Patients Using the heiQ

Dry Eye Disease (DED)is a chronic disease without a cure. Empowering patients to engage in better self-care requires knowledge of their disease and skills in self-management, which can lea...

Self-Management Addressing Heart Disease Risk Trial

The purpose of this research study is to learn whether or not people with bipolar disorder can reduce their risk of heart disease and related conditions by having a Care Manager provide se...

Postoperative Canadian Oral Anticoagulation Self-Management (Post-COAGS) Trial

This study will measure the efficacy and safety of an early postoperative anticoagulation self-management program, using the CoaguChek S device, in patients undergoing mechanical valve rep...

Companies [1186 Associated Companies listed on BioPortfolio]

Abingworth Management Ltd

Abingworth is a vital player among life science venture capital investors on both sides of the Atlantic, with offices in London and Palo Alto. Abingworth has funds under management of over $300 millio...

Abingworth Management Inc

Abingworth is a long-established venture capital firm dedicated to the life sciences sector on both sides of the Atlantic. The company invests across all stages of development, including early-stage a...

Avila Therapeutics, Inc.

Avila focuses on design and development of targeted covalent drugs to achieve best-in-class outcomes that cannot be achieved through traditional chemistries. This approach is call...

Intellikine, Inc.

Intellikine is a private, clinical-stage company focused on the discovery and development of innovative small molecule drugs targeting the PI3K/mTOR pathway. Intellikine recently announced the start ...

RD Management LLC

Specializing in the retail sector for more than 40 years, RD Management owns and operates more than 18 million square feet of neighborhood and community shopping centers throughou...

More Information about "Abingworth Management Inc" on BioPortfolio

We have published hundreds of Abingworth Management Inc news stories on BioPortfolio along with dozens of Abingworth Management Inc Clinical Trials and PubMed Articles about Abingworth Management Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Abingworth Management Inc Companies in our database. You can also find out about relevant Abingworth Management Inc Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record